Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Nature|December 12, 2003
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1Joseph T Opferman, Anthony Letai, Caroline Beard, et al.Science (New York, N.Y.)|February 19, 2005
Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cellsJoseph T Opferman, Hiromi Iwasaki, Christy C Ong, et al.Oncotarget|June 10, 2011
p21-activated kinase 1: PAK'ed with potentialChristy C Ong, Adrian M Jubb, Wei Zhou, et al.Genes & Development|January 21, 2003
Proapoptotic BID is required for myeloid homeostasis and tumor suppressionSandra S Zinkel, Christy C Ong, David O Ferguson, et al.Oncotarget|January 19, 2015
Group I Paks as therapeutic targets in NF2-deficient meningiomaHoi-Yee Chow, Biao Dong, Sergio G Duron, et al.Molecular & Cellular Proteomics : MCP|April 24, 2013
Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomicsFlorian Gnad, Amy Young, Wei Zhou, et al.Molecular Cancer Therapeutics|July 8, 2025
KRAS codon-specific mutations differentially toggle PI3K pathway signaling and alter sensitivity to inavolisib (GDC-0077)Kyung W Song, Christy C Ong, Eva Lin, et al.Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsChristy C Ong, Adrian M Jubb, Peter M Haverty, et al.Journal of the National Cancer Institute|March 29, 2013
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanomaChristy C Ong, Adrian M Jubb, Diana Jakubiak, et al.The Journal of Pathology|July 31, 2014
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibitionWei Zhou, Adrian M Jubb, Karen Lyle, et al.Pageof 2